全文获取类型
收费全文 | 256篇 |
免费 | 23篇 |
专业分类
279篇 |
出版年
2021年 | 3篇 |
2016年 | 6篇 |
2015年 | 8篇 |
2014年 | 7篇 |
2013年 | 16篇 |
2012年 | 6篇 |
2011年 | 5篇 |
2010年 | 3篇 |
2008年 | 6篇 |
2007年 | 8篇 |
2006年 | 12篇 |
2004年 | 5篇 |
2003年 | 3篇 |
2002年 | 7篇 |
1998年 | 6篇 |
1996年 | 4篇 |
1995年 | 4篇 |
1992年 | 3篇 |
1990年 | 4篇 |
1989年 | 4篇 |
1987年 | 3篇 |
1984年 | 3篇 |
1983年 | 3篇 |
1982年 | 5篇 |
1981年 | 9篇 |
1980年 | 6篇 |
1978年 | 3篇 |
1973年 | 5篇 |
1971年 | 5篇 |
1970年 | 4篇 |
1969年 | 7篇 |
1968年 | 5篇 |
1966年 | 2篇 |
1964年 | 3篇 |
1963年 | 5篇 |
1962年 | 4篇 |
1961年 | 5篇 |
1960年 | 3篇 |
1959年 | 3篇 |
1958年 | 5篇 |
1957年 | 7篇 |
1956年 | 4篇 |
1955年 | 2篇 |
1954年 | 2篇 |
1953年 | 3篇 |
1951年 | 2篇 |
1950年 | 4篇 |
1949年 | 2篇 |
1944年 | 2篇 |
1936年 | 2篇 |
排序方式: 共有279条查询结果,搜索用时 7 毫秒
31.
Human T-lymphocyte cytotoxicity and proliferation directed by a single chimeric TCRzeta /CD28 receptor. 总被引:10,自引:0,他引:10
John Maher Renier J Brentjens Gertrude Gunset Isabelle Rivière Michel Sadelain 《Nature biotechnology》2002,20(1):70-75
Artificial receptors provide a promising approach to target T lymphocytes to tumor antigens. However, the receptors described thus far produce either an activation or a co-stimulatory signal alone, thus limiting the spectrum of functions accomplished by the genetically modified cells. Here we show that human primary T lymphocytes expressing fusion receptors directed to prostate-specific membrane antigen (PSMA) and containing combined T-cell receptor-zeta (TCRzeta), and CD28 signaling elements, effectively lyse tumor cells expressing PSMA. When stimulated by cell-surface PSMA, retrovirally transduced lymphocytes undergo robust proliferation, expanding by more than 2 logs in three weeks, and produce large amounts of interleukin-2 (IL-2). Importantly, the amplified cell populations retain their antigen-specific cytolytic activity. These data demonstrate that fusion receptors containing both TCR and CD28 signaling moieties are potent molecules able to redirect and amplify human T-cell responses. These findings have important implications for adoptive immunotherapy of cancer, especially in the context of tumor cells that fail to express major histocompatibility complex antigens and co-stimulatory molecules. 相似文献
32.
Fluorimetric measurements and chromatin condensation patterns of nuclei from 3T3 cells throughout G1
Gertrude C. Moser Robert J. Fallon Harriet K. Meiss 《Journal of cellular physiology》1981,106(2):293-301
Using two cytological methods based on nuclear morphology, quinacrine dihydrochloride (QDH) staining and premature chromosome condensation (PCC), it has been possible to identify cell cyle positions within G1 of growing and arrested 3T3 cells. The fluorescent intensity of QDH-stained interphase cells appears to decrease as the cells pass from mitosis to S phase. Likewise, the length and thickness of prematurely condensed chromatids can be related to the cells' position within the G1 period. Data are presented that deal with three interrelated topics: (1) We determined by fluorometric measurements of nuclei from 3T3 cells that the visual observation of the decrease in QDH fluorescence during G1 reflects an actual decrease in total fluorescence and not a dispersion of the fluorescent chromatin in a larger nuclear area. (2) We correlated the results obtained by QDH staining with those of PCC on the same cell samples blocked in G1 by different conditions. Serum-starved and contact-inhibited cell nuclei had the highest intensity, hydroxyurea-treated ones had the lowest intensity, while that of isoleucine-deprived cells was in between. The same relative order of G1 positions was obtained based on PCC morphology. Thus, both methods monitor the state of chromatin condensation and can be used to identify cell cycle position within G1.(3) We showed with both methods that the states of chromatin resulting from the various G1 blocking conditions differ from each other. 相似文献
33.
Feichtner S Inführ D Achatz-Straussberger G Schmid D Karnowski A Lamers M Rhyner C Crameri R Achatz G 《Journal of immunology (Baltimore, Md. : 1950)》2008,180(8):5499-5505
The classical allergic reaction starts seconds or minutes after Ag contact and is committed by Abs produced by a special subset of B lymphocytes. These Abs belong to the IgE subclass and are responsible for Type I hyperreactivity reactions. Treatment of allergic diseases with humanized anti-IgE Abs leads primarily to a decrease of serum IgE levels. As a consequence, the number of high-affinity IgE receptors on mast cells and basophils decreases, leading to a lower excitability of the effector cells. The biological mechanism behind anti-IgE therapy remains partly speculative; however, it is likely that these Abs also interact with membrane IgE (mIgE) on B cells and possibly interfere with IgE production. In the present work, we raised a mouse mAb directed exclusively against the extracellular membrane-proximal domain of mIgE. The interaction between the monoclonal anti-mIgE Ab and mIgE induces receptor-mediated apoptosis in vitro. Passive immunization experiments lead to a block of newly synthesized specific IgEs during a parallel application of recombinant Bet v1a, the major birch pollen allergen. The decrease of allergen-specific serum IgE might be related to tolerance-inducing mechanisms stopping mIgE-displaying B cells in their proliferation and differentiation. 相似文献
34.
35.
36.
Maud Condomines Jon Arnason Reuben Benjamin Gertrude Gunset Jason Plotkin Michel Sadelain 《PloS one》2015,10(6)
Adoptive T cell therapy represents a promising treatment for cancer. Human T cells engineered to express a chimeric antigen receptor (CAR) recognize and kill tumor cells in a MHC-unrestricted manner and persist in vivo when the CAR includes a CD28 costimulatory domain. However, the intensity of the CAR-mediated CD28 activation signal and its regulation by the CTLA-4 checkpoint are unknown. We investigated whether T cells expressing an anti-CD19, CD3 zeta and CD28-based CAR (19-28z) displayed the same proliferation and anti-tumor abilities than T cells expressing a CD3 zeta-based CAR (19z1) costimulated through the CD80/CD28, ligand/receptor pathway. Repeated in vitro antigen-specific stimulations indicated that 19-28z+ T cells secreted higher levels of Th1 cytokines and showed enhanced proliferation compared to those of 19z1+ or 19z1-CD80+ T cells. In an aggressive pre-B cell leukemia model, mice treated with 19-28z+ T cells had 10-fold reduced tumor progression compared to those treated with 19z1+ or 19z1-CD80+ T cells. shRNA-mediated CTLA-4 down-regulation in 19z1-CD80+ T cells significantly increased their in vivo expansion and anti-tumor properties, but had no effect in 19-28z+ T cells. Our results establish that CTLA-4 down-regulation may benefit human adoptive T cell therapy and demonstrate that CAR design can elude negative checkpoints to better sustain T cell function. 相似文献
37.
38.
39.
Gertrude E. G. Pearson 《CMAJ》1937,36(5):516-517
40.